MentionFox
Home › funding signals › 511 Therapeutics, Inc.
Company · SEC filings

511 Therapeutics, Inc. funding history

Before you sign with, sell to or invest in 511 Therapeutics, Inc.

MentionFox check on 511 Therapeutics, Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/company/511-therapeutics-inc

Check 511 Therapeutics, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about 511 Therapeutics, Inc.?

Based on the records MentionFox holds for this company. No flag is not a clearance.

511 Therapeutics, Inc. has 2 Form D filings on record, from 2022-10-06 to 2026-10-30. Together its new offerings report $550K sold.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

511 Therapeutics, Inc.: Raised $500K, Form D filed 2026-10-30
Share on LinkedIn Share on X Download image

Keep reading

More on this company and the records around it.

this company elsewhere on the record

What do you want to do with 511 Therapeutics, Inc.?

Is 511 Therapeutics, Inc. a real, registered company?

511 Therapeutics, Inc. is a registered filer with the SEC (CIK 1946264) and has filed since 2022-10-06. 2 filings are on record, the latest on 2026-10-30.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs 511 Therapeutics, Inc.?

511 Therapeutics, Inc.'s filings name Shuguang Zhang, Uwe Sleytr, Yancen Lu and 1 more as its officers, directors or promoters.

How much has 511 Therapeutics, Inc. raised?

Its new offerings report $550K sold across 2 offerings, as its own filings state.

Run the free check on 511 Therapeutics, Inc. →

Based
CAMBRIDGE, MASSACHUSETTS
Year formed
2022
Industry group
Biotechnology
Filings
2
Raised (new offerings)
$550K

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-10-30New offering
first sale 2026-10-21
$500K$1Mdetails · SEC filing
2022-10-06New offering
first sale 2022-09-23
$50K$600KSEC filing

Want the whole picture on 511 Therapeutics, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on 511 Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on 511 Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from 511 Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Filings & events

Fundraising filings

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for 511 Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/511-therapeutics-inc
Last updated 2026-11-04
Primary record: SEC filing 1 · SEC filing 2
How much has 511 Therapeutics, Inc. raised? $550K in 2 SEC filings. MentionFox, 2026-11-04. https://mentionfox.com/company/511-therapeutics-inc